4,090
Views
19
CrossRef citations to date
0
Altmetric
Research Articles

Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment

, , , ORCID Icon, , , & show all
Pages 1212-1231 | Received 20 Feb 2022, Accepted 21 Mar 2022, Published online: 09 Apr 2022

References

  • Abd-Allah H, Abdel-Aziz RT, Nasr M. (2020). Chitosan nanoparticles making their way to clinical practice: a feasibility study on their topical use for acne treatment. Int J Biol Macromol 156:262–70.
  • Abd-Allah H, Kamel AO, Sammour OA. (2016). Injectable long acting chitosan/tripolyphosphate microspheres for the intra-articular delivery of lornoxicam: optimization and in vivo evaluation. Carbohydr Polym 149:263–73.
  • Abdel-Hafez SM, Hathout RM, Sammour OA. (2018). Tracking the transdermal penetration pathways of optimized curcumin-loaded chitosan nanoparticles via confocal laser scanning microscopy. Int J Biolo Macromol 108:753–64.
  • Abdel-Salam FS, Mahmoud AA, Ammar HO, Elkheshen SA. (2017). Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate. J Liposome Res 27:41–55.
  • Aiyalu R, Govindarjan A, Ramasamy A. (2016). Formulation and evaluation of topical herbal gel for the treatment of arthritis in animal model. Braz J Pharm Sci 52:493–507.
  • Alam S, Aslam M, Khan A, et al. (2016). Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail. Drug Deliv 23:601–9.
  • Ali ME, Lamprecht A. (2017). Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles. Int J Pharm 516:170–7.
  • Ali SM, Yosipovitch G. (2013). Skin pH: from basic science to basic skin care. Acta Derm Venereol 93:261–9.
  • Al‐Rashed MM, Niknezhad S, Jana SC. (2019). Mechanism and factors influencing formation and stability of chitosan/lignosulfonate nanoparticle. Macromol Chem Phys 220:180–96.
  • Anbar TS, El‐Ammawi TS, Barakat MT, et al. (2012). A new morphometric technique for assessment of melanization in skin of guinea pig. Photodermatol Photoimmunol Photomed 28:42–6.
  • Anbar TS, Moftah NH, El-Khayyat MA, et al. (2015). The changes in melanocyte number and melanin density occurring in vitiligo patches during 180 days of narrow band-ultraviolet B therapy. J Egypt Women’s Dermatol Soc 12:10–8.
  • Ayumi NS, Sahudin S, Hussain Z, et al. (2019). Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization. Drug Deliv Transl Res 9:482–96.
  • Bhumkar DR, Pokharkar VB. (2006). Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note. Aaps Pharmscitech 7:E138–E143.
  • Boudouaia N, Bengharez Z, Jellali S. (2019). Preparation and characterization of chitosan extracted from shrimp shells waste and chitosan film: application for Eriochrome black T removal from aqueous solutions. App Water Sci 9:1–12.
  • Bsieso EA, Nasr M, Moftah NH, et al. (2015). Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine 10:2017–31.
  • Butwong N, Kunawong T, Luong JH. (2020). Simultaneous analysis of hydroquinone, arbutin, and ascorbyl glucoside using a nanocomposite of Ag@ AgCl nanoparticles, Ag2S nanoparticles, multiwall carbon nanotubes, and chitosan. Nanomater 10:1583–96.
  • Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. (1997). Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63:125–32.
  • Chauhan N, Dilbaghi N, Gopal M, et al. (2017). Development of chitosan nanocapsules for the controlled release of hexaconazole. Int J Biol Macromol 97:616–24.
  • Chen H, Chang X, Weng T, et al. (2004). Study of microemulsion systems for transdermal delivery of triptolide. J Control Release 98:427–36.
  • Chen MX, Alexander KS, Baki G. (2016). Formulation and evaluation of antibacterial creams and gels containing metal ions for topical application. J Pharm 2016:150–63.
  • Chen Y, Siddalingappa B, Chan PH, Benson HA. (2008). Development of a chitosan‐based nanoparticle formulation for delivery of a hydrophilic hexapeptide. Dalargin. Pept Sci 90:663–70.
  • Contri R, Fiel L, Alnasif N, et al. (2016). Skin penetration and dermal tolerability of acrylic nanocapsules: Influence of the surface charge and a chitosan gel used as vehicle. Int J Pharm 507:12–20.
  • Debnath SK, Saisivam S, Debanth M, Omri A. (2018). Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of prothionamide. PLoS One 13:e0190976–211.
  • Delan WK, Zakaria M, Elsaadany B, et al. (2020). Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: optimization using Box–Behnken design, stability and in vivo study. Int J Pharm 577:119–28.
  • Dyab AK, Abdallah EM, Ahmed SA, Rabee MM. (2016). Fabrication and characterisation of novel natural Lycopodium clavatum sporopollenin microcapsules loaded in-situ with nano-magnetic humic acid-metal complexes. JEAS 06:109–17.
  • El-Kayal M, Nasr M, Elkheshen S, Mortada N. (2019). Colloidal (–)-epigallocatechin-3-gallate vesicular systems for prevention and treatment of skin cancer: a comprehensive experimental study with preclinical investigation. Euro J Pharm Sci 137:104–19.
  • ElShazly SA, AlAkra TM, Sukar NA, Zedan AM. (2021). The genetic and histological effect of chitosan and selenium nanoparticles in eliminating the side effects of soft drink consumption. Ann Rom Socr Cell Biol 25:17044–63.
  • Fitzpatrick T, Quevedo W, Jr Pathak M, Jimbow K. (1975). Role of light in human skin color variation. Am J Phys Anthropol 43:393–408.
  • Gulati N, Nagaich U, Saraf SA. (2013). Intranasal delivery of chitosan nanoparticles for migraine therapy. Sci Pharm 81:843–54.
  • Gupta R, Gupta GD. (2017). Formulation development and evaluation of anti-inflammatory potential of Cordia obliqua topical gel on animal mode. Pharmacogn J 9:560–74.
  • Habib BA, Sayed S, Elsayed GM. (2018). Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study-Box–Cox transformation practical example. Euro J Pharm Sci 115:352–61.
  • Hassan MI, Mohamed AF, Taher FA, Kamel MR. (2016). Antimicrobial activities of chitosan nanoparticles prepared from Lucilia cuprina maggots (Diptera: Calliphoridae). J Egypt Soc Parasitol 46:563–70.
  • Hatem S, El Hoffy NM, Elezaby RS, et al. (2020). Background and different treatment modalities for melasma: conventional and nanotechnology-based approaches. J Drug Deliv Sci Technol 15:101–18.
  • Hatem S, Nasr M, Moftah NH, et al. (2018). Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv 15:927–35.
  • Ibrahim ZA, Gheida SF, El Maghraby GM, Farag ZE. (2015). Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. J Cosmet Dermatol 14:113–23.
  • Jacobus Berlitz S, De Villa D, Inacio LAM, et al. (2019). Azelaic acid-loaded nanoemulsion with hyaluronic acid–a new strategy to treat hyperpigmentary skin disorders. Drug Dev Ind Pharm 45:642–50.
  • Jana S, Trivedi MK, Tallapragada RM, et al. (2015). Characterization of physicochemical and thermal properties of chitosan and sodium alginate after biofield treatment. Pharm Anal Acta 6:512–23.
  • Kafedjiiski K, Jetti RK, Föger F, et al. (2007). Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery. Int J Pharm 343:48–58.
  • Karimi M, Avci P, Ahi M, et al. (2013). Evaluation of chitosan-tripolyphosphate nanoparticles as a p-shRNA delivery vector: formulation, optimization and cellular uptake study. J Nanopharm Drug Deliv 1:266–78.
  • Khalil RM, El-Bary AA, Kassem MA, et al. (2013). Influence of formulation parameters on the physicochemical properties of meloxicam-loaded solid lipid nanoparticles. Egypt Pharm J 12:63–77.
  • Khunger N, Sarkar R, Jain R. (2004). Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark‐skinned patients. Dermatol Surg 30:756–60.
  • Kim H, Jung S, Yeo S, et al. (2019). Characteristics of skin deposition of itraconazole solubilized in cream formulation. Pharmaceutics 11:195–216.
  • Kwon SH, Hwang YJ, Lee SK, Park KC. (2016). Heterogeneous pathology of melasma and its clinical implication. IJMS 17:824–33.
  • Larrañeta E, Henry M, Irwin NJ, et al. (2018). Synthesis and characterization of hyaluronic acid hydrogels crosslinked using a solvent-free process for potential biomedical applications. Carbohydr Polym 181:1194–205.
  • Lewandowska K, Sionkowska A, Grabska S, et al. (2016). The miscibility of collagen/hyaluronic acid/chitosan blends investigated in dilute solutions and solids. J Mol Liq 220:726–30.
  • Loganathan V, Manimaran S, Jaswanth A, et al. (2001). The effects of polymers and permeation enhancers on releases of flurbiprofen from gel formulations. Indian J Pharm Sci 63:200–16.
  • Luo Y, Kirker KR, Prestwich GD. (2000). Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release 69:169–84.
  • Lupo MP, Cole AL. (2007). Cosmeceutical peptides. Dermatol Ther 20:343–9.
  • Lusiana RA, Putri Protoningtyas W, Ricky Wijaya A, et al. (2017). Chitosan-tripoly phosphate (CS-TPP) synthesis through cross-linking process: the effect of concentration towards membrane mechanical characteristic and urea permeation. Orient J Chem 33:2913–9.
  • Machado-Pinto J, de Fatima Melo Borges M, Magalhaes G. (2006). A review of melasma, part 1: etiopathogenic factors, clinical and histopathologic evaluations. Cosmet Dermatol-Cedar Knolls 19:683–7.
  • Martins AF, de Oliveira DM, Pereira AG, et al. (2012). Chitosan/TPP microparticles obtained by microemulsion method applied in controlled release of heparin. Int J Biol Macromol 51:1127–33.
  • Masarudin MJ, Cutts SM, Evison BJ, et al. (2015). Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnol Sci Appl 8:67–78.
  • Mashru R, Sutariya V, Sankalia M, Parikh P. (2005). Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm 31:25–34.
  • Nair RS, Morris A, Billa N, Leong C-O. (2019). An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery. Aaps Pharmscitech 20:1–13.
  • Nasr M, Awad GA, Mansour S, et al. (2011). A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres. J Pharm Sci 100:612–21.
  • Nasti A, Zaki NM, de Leonardis P, et al. (2009). Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res 26:1918–30.
  • Neagu N, Conforti C, Agozzino M, et al. (2021). Melasma treatment: a systematic review. J Dermatol Treat 15:1–39.
  • Nycz JE, Malecki G, Morag M, et al. (2010). Arbutin: Isolation, X-ray structure and computional studies. J Mol Struct 980:13–7.
  • Omar Zaki SS, Ibrahim MN, Katas H. (2015). Particle size affects concentration-dependent cytotoxicity of chitosan nanoparticles towards mouse hematopoietic stem cells. J Nanotechnol 2015:1–245.
  • Omwoyo WN, Moloto MJ. (2019). Encapsulation of ibuprofen into solid lipid nanoparticles for controlled and sustained release using emulsification solvent evaporation technique. Catalysts 45:106–15.
  • Özcan I, Azizoğlu E, Senyiğit T, et al. (2013). Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations. Int J Nanomedicine 8:461–72.
  • Pande V, Patel S, Patil V, Sonawane R. (2014). Design expert assisted formulation of topical bioadhesive gel of sertaconazole nitrate. Adv Pharma Bull 4:121–32.
  • Pandya A, Berneburg M, Ortonne JP, Picardo M. (2006). Guidelines for clinical trials in melasma. Bri J Dermatol 156:21–8.
  • Parente M, Ochoa Andrade A, Ares G, et al. (2015). Bioadhesive hydrogels for cosmetic applications. Int J Cosmet Sci 37:511–8.
  • Pervaiz F, Saleem M, Ashames A, et al. (2020). Development and ex-vivo skin permeation studies of finasteride–poly (lactic acid-co-glycolic acid) and minoxidil–chitosan nanoparticulate systems. J Bioact Compat Polym 35:77–91.
  • Prabha N, Mahajan VK, Mehta KS, et al. (2014). Cosmetic contact sensitivity in patients with melasma: results of a pilot study. Dermatol Res Practice 2014:1–98.
  • Prignano F, Ortonne JP, Buggiani G, Lotti T. (2007). Therapeutical approaches in melasma. Dermatol Clin 25:337–42.
  • Quilaqueo N, Navarrete F, Sandoval C, et al. (2021). Marcadores Inmunohistoquímicos en el Diagnóstico Diferencial de Melanoma y Nevos en Humanos. Int J Morphol 39:1509–15.
  • Rahat I, Imam SS, Md R, et al. (2021). Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments. Drug Deliv 28:973–84.
  • Ramesh Y, Sireesha V. (2017). Transdermal patch of ramipril loaded chitosan nanoparticles dispersed in carbopol gel. J Drug DelivTher 7:56–65.
  • Safdar R, Omar AA, Arunagiri A, et al. (2019). Potential of chitosan and its derivatives for controlled drug release applications–a review. J Drug Deliv Scie Technol 49:642–59.
  • Saleh F, Moftah NH, Abdel ‐Azim E, et al. (2018). Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: a comparative clinical, histopathological, and immunohistochemical study. J Cosmet Dermatol 17:319–27.
  • Samy AM, Ghorab MM, Shadeed SG, Mazyed EA. (2013). Formulation and evaluation of different transdermal drug delivery systems of ketoprfen. Int J Pharm Pharm Sci 5:452–63.
  • Shankar K, Godse K, Aurangabadkar S, et al. (2014). Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther 4:165–86.
  • Sobhi RM, Sobhi AM. (2012). A single‐blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma. J Cosmet Dermatol 11:65–71.
  • Sripriya R, Kumar R. (2015). A novel enzymatic method for preparation and characterization of collagen film from swim bladder of fish Rohu (Labeo rohita). Food Nutr Sci 6:1468–79.
  • Sugimoto K, Nishimura T, Nomura K, et al. (2004). Inhibitory effects of α-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biol Pharma Bull 27:510–4.
  • Teja S, Damodharan N. (2018). 23 full factorial model for particle size optimization of methotrexate loaded chitosan nanocarriers: A design of experiments (DoE) approach. BioMed Res Int 2018:1–317.
  • Trommer H, Wartewig S, Böttcher R, et al. (2003). The effects of hyaluronan and its fragments on lipid models exposed to UV irradiation. Int J Pharm 254:223–34.
  • Vaezifar S, Razavi S, Golozar MA, et al. (2013). Effects of some parameters on particle size distribution of chitosan nanoparticles prepared by ionic gelation method. J Clust Sci 24:891–903.
  • Varun TK, Senani S, Jayapal N, et al. (2017). Extraction of chitosan and its oligomers from shrimp shell waste, their characterization and antimicrobial effect. Vet World 10:170–82.
  • Villetti M, Crespo J, Soldi M, et al. (2002). Thermal degradation of natural polymers. J Therm Anal Calorim 67:295–303.
  • Wan A. j, Sun Y, Li W. t, Li H. (2008). Transmission electron microscopy and electron diffraction study of BSA-loaded quaternized chitosan nanoparticle. J Biomed Mater Res Part B: Appl Biomat 86:197–207.
  • Wang Y-W, Jou C-H, Hung C-C, Yang M-C. (2012). Cellular fusion and whitening effect of a chitosan derivative coated liposome. Colloids Surf B Biointerfaces 90:169–76.
  • Wani TU, Raza SN, Khan NA. (2019). Rosmarinic acid loaded chitosan nanoparticles for wound healing in rats. Ijpsr 10:1138–47.
  • Wattanakrai P, Mornchan R, Eimpunth S. (2010). Low‐fluence Q‐switched neodymium‐doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asian. Dermatol Surg 36:76–87.
  • Wen AH, Choi MK, Kim DD. (2006). Formulation of liposome for topical delivery of arbutin. Arch Pharm Res 29:1187–92.
  • Xie J, Ji Y, Xue W, et al. (2018). Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery. Colloids Surf B Biointerfaces 172:323–9.
  • Yang C, Fan W, Zhang R, et al. (2018). Study on transglucosylation properties of amylosucrase from Xanthomonas campestris pv. Campestris and its application in the production of α-arbutin. Catalysts 9:5–16.
  • Zhang Y, Yang Y, Tang K, et al. (2008). Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci 107:891–7.
  • Zhu W, Gao J. (2008). The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc 16:2041–56.
  • Zhuang YL, Sun LP. (2012). Anti-melanogenic activities of collagen peptides from jellyfish (Stomolophus meleagris). Adv Mater Res 2012:1089–99.